Table 4 Effect of treatments on blood glucose, HbA1c, serum C-peptide, insulin, IL-6 and TNF−α
Group I (Control) | Group II (PO-Control) | Group III (Diabetic) | Group IV (PO-diabetic) | |
|---|---|---|---|---|
Blood Glucose | 119.8 ± 1.0 | 109.0 ± 1.3 | a293.2 ± 2.4 | a,b125.0 ± 1.3 |
C peptide (ng/mL) | 0.97 ± 0.03 | 1.00 ± 0.04 | a,0.48 ± 0.02 | b0.94 ± 0.02 |
Hb A1c (%) | 4.99 ± 0.06 | 5.01 ± 0.07 | a10.35 ± 0.12 | a,b6.97 ± 0.02 |
Insulin (mIU/L) | 35.50 ± 0.09 | 36.02 ± 0.08 | a18.97 ± 0.09 | b33.50 ± 0.08 |
TNFa (pg/ml) | 34.90 ± 0.17 | 34.77 ± 0.21 | a49.70 ± 0.55 | b35.20 ± 0.24 |
IL- 6 (pg/ml) | 15.02 ± 0.13 | 14.91 ± 0.12 | a28.90 ± 0.34 | b16.26 ± 0.17 |